Atherosclerosis is a slow-building disease of the arteries in which fatty deposits, immune cells, and fibrous tissue accumulate inside vessel walls, gradually narrowing the channel blood flows through and sometimes triggering sudden, life-threatening events like heart attacks and strokes. The process typically begins decades before symptoms appear, driven by a combination of cholesterol infiltration and chronic inflammation. What makes atherosclerosis especially dangerous is not the narrowing itself but the possibility that a plaque becomes unstable and ruptures, forming a blood clot that can block an artery within minutes.
Where Plaques Begin
Arteries are not equally vulnerable everywhere. Plaques tend to form at bends and branch points, where blood flow becomes turbulent instead of smooth. At these spots, the inner lining of the artery, the endothelium, experiences low or oscillatory shear stress. That mechanical disruption weakens the tight connections between endothelial cells and damages the thin protective layer (called the glycocalyx) that normally acts as a barrier. The result is increased permeability, which lets lipoproteins and inflammatory cells slip through into the artery wall.1PubMed Central. Low or oscillatory shear stress and endothelial permeability in atherosclerosis
Once low-density lipoprotein (LDL) particles cross the endothelium, they enter the space beneath it known as the intima. There, LDL can become chemically modified, particularly through oxidation. The body treats this oxidized LDL as a threat and recruits immune cells, mainly monocytes, which migrate into the artery wall and mature into macrophages. These macrophages are equipped with receptors that scoop up oxidized LDL aggressively. Unlike most cellular receptors, these scavenger receptors are not dialed down when the cell has taken in enough cholesterol. So the macrophage keeps engulfing lipids until it becomes bloated with cholesterol, transforming into what researchers call a foam cell.2PubMed. Macrophage scavenger receptors and foam cell formation Foam cells are a hallmark of early atherosclerosis and the first visible sign that a plaque is forming.3PubMed. Hypoxia enhances lipid uptake in macrophages: role of the scavenger receptors Lox1, SRA, and CD36
Macrophages are not designed to handle this level of cholesterol accumulation. They become dysfunctional and eventually die, spilling their lipid-laden contents into the artery wall.4PubMed Central. Oxidized LDL phagocytosis during foam cell formation in atherosclerotic plaques relies on a PLD2-CD36 functional interdependence Under normal circumstances, dead cells are cleaned up efficiently by neighboring cells in a process called efferocytosis. But inside a growing plaque, this cleanup mechanism becomes impaired, and dead cell debris accumulates into a soft, lipid-rich core. That failure to clear dead cells is now recognized as a major driver of plaque growth and instability.5PubMed Central. The Role of Efferocytosis in Atherosclerosis
How a Plaque Grows and Remodels
As foam cells accumulate and die, the artery wall responds by trying to wall off the damage. Smooth muscle cells, which normally sit in the deeper layers of the artery and help it contract, begin to change their behavior. Instead of staying put and doing their contractile job, they migrate toward the developing plaque and start producing structural proteins and enzymes that reshape the tissue around the lesion. This shift, known as phenotypic switching, means smooth muscle cells take on new roles: some produce collagen that forms a fibrous cap over the plaque, while others contribute to the lesion’s growth and remodeling in ways that can be either helpful or harmful.6PubMed Central. Phenotypic Switching of Vascular Smooth Muscle Cells in Atherosclerosis
A mature plaque, then, is not just a blob of fat. It is a complex structure with a lipid-rich necrotic core surrounded by smooth muscle cells, immune cells, collagen, and often calcium deposits. Think of it as a kind of abscess within the artery wall, walled off by a fibrous cap of varying thickness. The fate of that plaque depends largely on the balance between the forces building up the cap and the forces tearing it down.
Inflammation as the Engine
Cholesterol gets the headlines, but inflammation is what keeps atherosclerosis moving forward. Inside the plaque, immune cells detect danger signals from oxidized LDL, cholesterol crystals, and dead cell debris. One of the most important inflammatory pathways involves the NLRP3 inflammasome, an immune signaling complex that, once activated, triggers the release of powerful inflammatory molecules, particularly from a family of signaling proteins tied to interleukin-1. Cholesterol crystals and oxidized LDL are potent activators of this pathway, creating a self-reinforcing cycle: inflammation recruits more immune cells, which take up more lipid, which generates more inflammatory signals.7PubMed. NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
This is why atherosclerosis is often described as a chronic inflammatory disease rather than simply a cholesterol storage problem. The inflammatory component explains why some people with relatively modest cholesterol levels still develop severe disease, and why anti-inflammatory treatments have shown real benefits in clinical trials.
Stable Versus Unstable Plaques
Not all plaques are equally dangerous. A plaque with a thick fibrous cap, a small lipid core, and relatively little ongoing inflammation can narrow an artery significantly yet remain stable for years. It may cause symptoms like chest pain during exertion (angina) as blood flow becomes restricted, but it is unlikely to cause a sudden catastrophic event.
The real danger comes from vulnerable plaques. These have thin fibrous caps, large necrotic cores full of lipid and dead cell debris, and heavy infiltration by inflammatory cells that produce enzymes degrading the cap’s structural collagen. If the cap tears, the contents of the plaque are exposed to the bloodstream, triggering a rapid clotting response that can block the artery entirely within minutes.
Calcium plays a counterintuitive role here. Large, dense calcium deposits tend to make a plaque more rigid and, paradoxically, more stable. But tiny specks of calcium, called microcalcifications, embedded within the fibrous cap can actually increase the risk of rupture. The mismatch in stiffness between the calcified speck and the surrounding soft tissue concentrates mechanical stress at the boundary, weakening the cap.8PubMed Central. Small entities with large impact: microcalcifications and atherosclerotic plaque vulnerability This relationship is dose-dependent in a surprising direction: as calcification density increases, the risk of rupture tends to go down, because the plaque becomes more uniformly rigid.9PubMed Central. Coronary artery calcification and plaque stability: an optical coherence tomography study A heavily calcified artery on a CT scan may look alarming, but it is often more stable than a lightly calcified one with scattered micro-deposits in its cap.
When Plaques Cause Real Damage
Atherosclerosis is a systemic disease, meaning it affects arteries throughout the body, but the consequences depend on which artery is involved. In the coronary arteries that feed the heart, a ruptured plaque and the resulting blood clot can cause a heart attack by cutting off blood flow to a section of heart muscle.10Comprehensive Physiology. Pathophysiology of Myocardial Infarction In the carotid arteries of the neck, atherosclerosis is responsible for roughly 10 to 20 percent of all ischemic strokes, either by narrowing the vessel enough to choke off blood flow or by sending clot fragments upstream into the brain.11PubMed Central. A narrative review of the pathophysiology of ischemic stroke in carotid plaques
In the legs, atherosclerosis causes peripheral artery disease, which can produce cramping pain during walking and, in severe cases, tissue death requiring amputation. In the kidneys, it can contribute to chronic kidney disease and difficult-to-control blood pressure. In the arteries supplying the gut, it can cause abdominal pain after eating (mesenteric ischemia). The common thread is always the same: reduced or blocked blood flow to tissue that needs it.
One of the more unsettling aspects of the disease is that the first symptom can be the catastrophic event itself. A plaque may grow for decades with no outward sign. Many heart attacks occur in arteries that were only moderately narrowed, not severely blocked, because it was a vulnerable plaque that ruptured rather than a large stable one that finally closed off.
Risk Factors That Speed Things Up
Atherosclerosis is sometimes called a disease of modern life, but evidence from ancient mummies shows it has been around for thousands of years. What modern life does is accelerate the process. Several well-established risk factors feed directly into the mechanisms described above.
High LDL cholesterol, and particularly small dense LDL particles, is the most direct contributor. Small dense LDL is especially harmful because it penetrates the artery wall more easily, circulates longer in the bloodstream, and is more prone to oxidation than larger, more buoyant LDL particles.12PubMed Central. Small dense LDL: An underestimated driver of atherosclerosis
Diabetes accelerates atherosclerosis through several pathways. Chronically elevated blood sugar promotes the formation of advanced glycation end products (AGEs), which are chemically modified proteins that accumulate in the vessel wall. AGEs block the activity of nitric oxide, a molecule the endothelium uses to relax blood vessels and keep inflammation in check. They also increase endothelial permeability and trigger the production of reactive oxygen species, amplifying both the cholesterol infiltration and the inflammatory response that drives plaque growth.13PubMed. Advanced glycation end products: sparking the development of diabetic vascular injury Within the vessel wall, these AGEs interact with endothelial cells, macrophages, and smooth muscle cells alike, increasing the expression of adhesion molecules that recruit even more immune cells into the developing plaque.14PubMed. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes
High blood pressure damages arteries mechanically. The increased force stretches and injures the endothelium, stimulates the artery wall to thicken and stiffen, and impairs endothelial production of nitric oxide. This endothelial dysfunction makes the artery more susceptible to cholesterol infiltration and inflammation.15PubMed Central. Arterial stiffness and hypertension Smoking, meanwhile, damages the endothelium chemically through toxins in tobacco smoke, promotes oxidation of LDL, and raises blood pressure. These risk factors often cluster together, and their effects compound.
Detection and Risk Assessment
Because atherosclerosis is silent for so long, a key challenge is identifying people at high risk before their first event. Standard risk calculators use factors like age, sex, cholesterol levels, blood pressure, smoking status, and diabetes to estimate the likelihood of a heart attack or stroke over the next ten years. These tools do a reasonable job for most people, but they miss some individuals whose risk is higher than the numbers suggest.
Coronary artery calcium (CAC) scoring, which uses a low-dose CT scan to measure calcium deposits in the heart’s arteries, can add useful information on top of standard risk factors. In a large analysis, adding the CAC score to traditional risk prediction modestly improved the ability to distinguish who would go on to have an event from who would not.16PubMed Central. Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment Other markers that have been studied, including ankle-brachial index, high-sensitivity C-reactive protein, and family history, did not improve predictive accuracy in the same analysis when added to a standard calculator. CAC scoring is most useful for people in the intermediate-risk zone, where the decision to start medication is a toss-up and a score of zero can be reassuring.
For looking directly at plaques, intravascular imaging techniques like optical coherence tomography and intravascular ultrasound allow doctors to see the structure of a plaque from inside the artery during a catheterization procedure. These tools can identify features of vulnerability, like thin fibrous caps and large lipid pools, that are invisible on standard angiography.17PubMed. Intravascular modalities for detection of vulnerable plaque: current status They are used primarily in research settings and in patients already undergoing invasive procedures, not as screening tools for the general population.
Treatments That Target the Plaque
Statins remain the backbone of treatment. By lowering LDL cholesterol, they reduce the raw material entering the artery wall and slow the inflammatory process inside existing plaques. In many patients, statin therapy stabilizes plaques by shrinking the lipid core and thickening the fibrous cap, making rupture less likely even if the artery is still partially narrowed.
For patients who need more aggressive LDL lowering, PCSK9 inhibitors (drugs like evolocumab and alirocumab) can be added to statin therapy. The combination has been shown to promote plaque stability and drive regression of lipid-rich plaques. In imaging studies, patients on PCSK9 inhibitors plus statins showed greater reductions in the lipid content of their coronary plaques compared to patients on statins alone.18European Heart Journal – Cardiovascular Imaging. Clinical impact of PCSK9 inhibitor on stabilization and regression of lipid-rich coronary plaques: a near-infrared spectroscopy study This effect on plaque composition goes beyond what cholesterol numbers alone would predict, suggesting that PCSK9 inhibitors contribute to plaque stabilization through additional mechanisms.19PubMed Central. PCSK9 and Coronary Artery Plaque—New Opportunity or Red Herring?
Anti-inflammatory approaches represent a newer front. Colchicine, a drug long used for gout, has been repurposed at low doses for cardiovascular prevention. Research in the early twenty-first century demonstrated that low-dose colchicine can add to secondary prevention of major adverse cardiovascular events.20Arteriosclerosis, Thrombosis, and Vascular Biology. Colchicine’s Role in Cardiovascular Disease Management This finding supports the idea that targeting inflammation directly, not just cholesterol, can reduce the harm atherosclerosis causes.
Diabetes drugs have also shown unexpected vascular benefits. Two classes of medications originally developed for blood sugar control, SGLT2 inhibitors and GLP-1 receptor agonists, appear to exert direct effects on the blood vessel wall. These include reducing inflammation and oxidative stress within the endothelium and smooth muscle cells, limiting harmful vascular remodeling, and decreasing the tendency toward blood clot formation.21PubMed. Molecular Mechanisms Underlying the Cardiovascular Benefits of SGLT2i and GLP-1RA These vascular effects appear to go beyond what blood sugar control alone would explain, which is why these drugs are increasingly prescribed for cardiovascular protection even in patients whose diabetes is already well managed.
Sex Differences in Atherosclerosis
Women develop atherosclerosis on a delayed timeline compared to men, with rates of heart attack and stroke rising sharply after menopause. Estrogen appears to play a protective role through multiple mechanisms, including regulation of oxidative stress in the cardiovascular system.22PubMed Central. Protective Effects of Estrogen on Cardiovascular Disease Mediated by Oxidative Stress When estrogen levels decline after menopause, this protection fades and women’s cardiovascular risk climbs steeply.
Beyond timing, the pattern of disease often differs. Women are more likely to develop diffuse, non-obstructive atherosclerosis spread across many small vessels rather than the focal, large-vessel blockages more common in men. This means standard tests like angiography, which are designed to find significant narrowing in large arteries, can underestimate disease burden in women. The symptoms can differ too: women having a heart attack are more likely to experience shortness of breath, nausea, and fatigue rather than the classic crushing chest pain, which can delay diagnosis.
The Evolutionary Angle
One reason atherosclerosis is so common may lie in human evolutionary history. Our immune systems evolved under intense pressure from infections, parasites, and physical trauma. A robust inflammatory response was a survival advantage in environments where the main threats were acute and external. But that same aggressive immune response, when directed at cholesterol deposits inside artery walls over decades of modern lifespan, drives plaque formation. The ubiquity of atherosclerosis in contemporary populations may reflect a trade-off: natural selection favored a strong innate immune response that came at the cost of chronic arterial inflammation later in life.23PubMed. Atherosclerosis as the Damocles’ sword of human evolution: insights from nonhuman ape-like primates, ancient human remains, and isolated modern human populations In ancestral environments where few people lived past 40 and infections were the primary killer, that trade-off was invisible. In modern life, with longer lifespans and abundant caloric intake, it becomes the leading cause of death worldwide.
Gut Bacteria and Clonal Blood Cells
Newer research is exploring connections between atherosclerosis and body systems that seem, at first glance, unrelated to the heart. One area of growing interest is the gut microbiome. Certain gut bacteria produce a compound called TMAO (trimethylamine N-oxide) as a byproduct of metabolizing nutrients found in red meat and eggs. TMAO appears to promote inflammation and may contribute to plaque instability. A separate and even more recent discovery involves clonal hematopoiesis, a condition in which a mutation in a blood stem cell gives rise to a growing population of genetically altered immune cells. When these mutations knock out genes involved in regulating inflammation (such as TET2), the resulting immune cells appear more prone to driving atherosclerosis. Researchers have proposed that these two phenomena could interact in a feed-forward loop, where gut-derived TMAO and inflammation-prone immune cells each amplify the other’s contribution to cardiovascular risk.24PubMed Central. Clonal Hematopoiesis and Gut Microbiota-Derived TMAO as Candidate Amplifiers of Cardiovascular Inflammation: The CHIDT Hypothesis This is still hypothesis-level science, but it illustrates how the understanding of atherosclerosis continues to expand beyond cholesterol and blood pressure into immunology, genetics, and microbiology.